tofacitinib and Livedo-Reticularis

tofacitinib has been researched along with Livedo-Reticularis* in 1 studies

1 other study(ies) available for tofacitinib and Livedo-Reticularis

Article	Year
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Humans; Livedo Reticularis; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Diseases, Vascular; Skin Ulcer; Vascular Diseases	2020